The financing was used, in part, to support Aushon’s recent purchase of the SearchLight protein array business and technology assets from Thermo Fisher Scientific.
SearchLight assets are currently being integrated into Aushon, but its offerings will continue to be marketed under the SearchLight brand. The combined business will operate under the name Aushon BioSystems, with headquarters in Billerica, Massachusetts.
Peter Honkanen, CEO of Aushon, said: “This latest round of financing speaks directly to the strength of our company, and to a strategic vision that recognizes the tremendous impact that multiplexed assays and microarray technology can have in accelerating biomarker research. Our decision to acquire SearchLight is central to that vision.
“Not only will we be able to deliver reliable protein biomarker data to accelerate preclinical and clinical research, but our customers can now rely on a single, proven resource for all their biomarker research needs.”